New York Life Investment Management »

Century Therapeutics shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Century Therapeutics (IPSC) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Century Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Century Therapeutics held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Century Therapeutics by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $332k 100k 3.32
2023-09-30 $205k 103k 2.00
2023-06-30 $375k 119k 3.16
2023-03-31 $464k 134k 3.47

More positions owned by New York Life Investment Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Indexiq Etf Tr Candriam Us Larg (IQSU)
Indexiq Active Etf Tr Iq Mackay Esg Cr (ESGB)
Amazon (AMZN)
Indexiq Etf Tr Candriam Us Mid (IQSM)
NVIDIA Corporation (NVDA)
Indexiq Etf Tr Candriam Interna (IQSI)
Indexiq Etf Tr Iq 500 Int Etf (IQIN)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Indexiq Etf Tr Iq U.s. Small Ca (CSML)
Indexiq Etf Tr Iq Cbre Nexgen (ROOF)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Indexiq Etf Tr Ftse Internl Eqt (HFXI)

View all positions for New York Life Investment Management

Top funds holding Century Therapeutics

Casdin Capital
Avidity Partners Management
DAFNA Capital Management
Vanguard Group
Tang Capital Management
Baker Bros. Advisors
Federated Investors
Charles Schwab Investment Management
Millennium Management
Citadel Advisors
Jacobs Levy Equity Management
New York Life Investment Management
Wealth Enhancement Advisory Services
Bank of New York Mellon
Squarepoint Ops

View all funds holding Century Therapeutics